Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

US Patent 9624273 · Granted Apr 18, 2017

Estimated economic value: $3,251,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen screening system2021
Treatment methods2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Antigen screening system2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Antigen screening system2018
Vaccines against herpes simplex virus type 2: compositions and methods for elici2017
Vaccines against herpes simplex virus type 2: compositions and methods for elici2017